JR-8603

N/A

Report date: 2024/06/04 16:20:21
NME

Base Information

Drug NameJR-8603
Drug Alias NameJR8603JR-8603
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursStomach NeoplasmsColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesJiaRay GroupJiaRay Pharmaceuticals IncPharmaceutics International Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursStomach NeoplasmsColorectal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A